Related Experiment Video

Updated: Jan 1, 2026

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
08:08

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach

Published on: September 22, 2017

11.5K

Use of Cardiopulmonary Bypass for Treatment of Malignant Hyperthermia

Thomas Phillips1, Eric Zimmermann1, Chris Dukatz1

  • 1Oregon Health and Science University, Portland, OR.

Journal of Cardiothoracic and Vascular Anesthesia
|December 19, 2019
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ECMOcardiopulmonary bypassmalignant hyperthermiamitral valve replacement

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.8K
Protocol for Long Duration Whole Body Hyperthermia in Mice07:56

Protocol for Long Duration Whole Body Hyperthermia in Mice

Published on: August 25, 2012

11.9K

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
232
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
321